William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
William Blair on Acuity Brands (AYI): 'Lighting Survey Shows More of the Same; Expect In-Line Quarter'
-
William Blair on AAON Inc (AAON) Increased Borrowing: 'We view this as a positive for data center orders'
-
William Blair Reiterates Outperform Rating on Ultragenyx Pharma (RARE)
-
Azenta agrees to sell B Medical Systems unit for $63 million
-
Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.
-
Sanofi pushes ahead on adult vaccines with $2.2 billion Dynavax deal
-
Motive Files Registration Statement for Proposed Initial Public Offering
-
Medtronic files for IPO of diabetes unit MiniMed
-
Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed
-
UL Solutions underwriters exercise option for 1.9 million shares
-
UL Solutions Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Andersen closes $202.4 million IPO with full overallotment exercise
-
Andersen Announces Closing of its Initial Public Offering and Full Exercise of the Underwriters’ Over-Allotment Option
-
Medline closes $7.2 billion IPO with full underwriter option exercise
-
Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
PartsTrader Announces Agreement to Be Acquired by Enlyte, Accelerating Innovation Across the Collision Industry
-
Gunderson Dettmer Represents Client Andersen Group in its $176 million IPO
-
William Blair Starts Sotera Health (SHC) at Outperform
-
William Blair Downgrades Progressive Corp. (PGR) to Market Perform, 'set up to be the industry winner'
-
William Blair Downgrades Kemper Corp (KMPR) to Market Perform
-
William Blair Downgrades Allstate (ALL) to Market Perform
-
Kalaris Therapeutics raises $50 million in private placement
-
Kalaris Therapeutics Announces Oversubscribed $50.0 Million Private Placement
-
William Blair Downgrades VistaGen Therapeutics (VTGN) to Market Perform
-
Coursera to buy Udemy, creating $2.5 billion firm to target AI training
-
William Blair: 'SharkNinja is our top pick heading into 2026'
-
Andersen Announces Pricing of Initial Public Offering
-
Medline Announces Pricing of Upsized Initial Public Offering
-
Rekor Systems closes $15 million stock offering
-
Rekor Systems Announces Closing of $15.0 Million Underwritten Registered Direct Offering
-
Better Being Announces Strategic Transaction to Power Next Phase of Growth
-
Form D William Blair MB Investm
-
MIAX completes secondary offering of 7.8 million shares at $41 each
-
Miami International Holdings Announces Closing of Secondary Public Offering of Common Stock
-
William Blair: 'We Have No Concerns About Arista’s Durable Growth Prospects'
-
Rekor Systems prices $15 million direct offering at $1.75 per unit
-
Rekor Systems Announces Pricing of $15.0 Million Underwritten Registered Direct Offering
-
William Blair Starts The RealReal Inc. (REAL) at Outperform
-
William Blair Reiterates Outperform Rating on Apellis Pharmaceuticals (APLS)
-
William Blair Reiterates Outperform Rating on Arm Holdings (ARM)
-
William Blair Starts Aardvark Therapeutics Inc (AARD) at Outperform
-
Contineum Therapeutics prices $90 million public offering at $12.25 per share
-
Contineum Therapeutics Announces Pricing of Upsized $90.0 Million Public Offering
-
MIAX prices secondary offering of 6.75 million shares at $41 each
-
Miami International Holdings Announces Pricing of Secondary Public Offering of Common Stock
-
Form DEF 14A WILLIAM BLAIR FUNDS For: Jan 27
-
Contineum Therapeutics announces $75 million public offering
-
Contineum Therapeutics Announces Proposed $75.0 Million Public Offering
-
Presenting Companies and Schedule Announced for the 2026 ICR Conference
-
CenterOak Partners Announces Sale of Turf Masters Brands

